In Taipei, TAIWAN, on June 18, 2026, SL Science Holding Limited, a biotech company based in Taiwan focusing on cutting-edge cellular and gene therapies, revealed its financial performance for the entire year concluding on December 31, 2025. The Company, listed on Nasdaq as SLBT, shared these results without specifying the details.